ArticleSurgical endoscopy2026
Short-term outcomes of robotic-assisted distal pancreatectomy using domestic KangDuo Surgical Robot-2000 System versus Da Vinci Xi system: a two-center prospective observational cohort study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveRobotic surgery is a transformative approach for abdominal tumors. With the emergence of multiple robotic systems, evidence on their comparative oncological outcomes remains limited. This two-center prospective observational cohort study aimed to compare surgical efficacy and short-term oncological outcomes between the novel KangDuo Surgical Robot System-2000 (KD-SR-2000) and the Da Vinci Xi system in robot-assisted distal pancreatectomy (RDP).
methodsThis two-center prospective observational cohort study enrolled patients with pancreatic tumors who scheduled for RDP at Peking Union Medical College Hospital and Peking University First Hospital between December 2023 and May 2025. Eligible patients were assigned into either the KD-SR-2000 group (n = 33) or the Da Vinci Xi group (n = 50) in a non-randomized, non-blinded manner. Baseline demographics, perioperative parameters, postoperative complications, ergonomics, and hospitalization costs were prospectively collected and compared between groups.
resultsBaseline characteristics were balanced. One case in the Da Vinci Xi group was converted to laparotomy due to severe adhesions and splenic vein bleeding. No significant differences were observed in surgical success, conversion, spleen preservation, or 90-day mortality rates (all P > 0.05). NASA-TLX scores indicated higher physical demand, effort, and total workload in the KD-SR-2000 group, though differences were not significant (all P > 0.05). Major complications (Clavien-Dindo ≥ III) and specific complications showed no significant differences. The KD-SR-2000 group had significantly lower hospitalization costs ($8131.6 [7642.4-9960.7] vs. $9859.6 [9022.4-18,965.8], P < 0.001). Intraoperative blood loss, operation time, and postoperative stay did not differ significantly.
conclusionsIn this preliminary prospective observational study, the KD-SR-2000 system demonstrated comparable efficacy and safety to the Da Vinci Xi in the RDP procedure. While further improvements are needed in its ergonomic design, it possesses significant advantages in surgical costs and may be considered a viable alternative to the Da Vinci Xi system.
Indexed as
Identifiers
42637946What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.